デフォルト表紙
市場調査レポート
商品コード
1356052

世界のアデノシンデアミナーゼ欠損症市場:考察と予測 (2029年まで)

Global Adenosine Deaminase Deficiency Market Insights, Forecast to 2029

出版日: | 発行: QYResearch | ページ情報: 英文 79 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
世界のアデノシンデアミナーゼ欠損症市場:考察と予測 (2029年まで)
出版日: 2023年10月05日
発行: QYResearch
ページ情報: 英文 79 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、アデノシンデアミナーゼ欠損症 (Adenosine Deaminase Deficiency) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界のアデノシンデアミナーゼ欠損症の市場規模成長率:タイプ別, 2018 VS 2022 VS 2029
    • Adagen
    • Revcovi
  • 市場:用途別
    • 世界のアデノシンデアミナーゼ欠損症の市場規模成長率:用途別, 2018 VS 2022 VS 2029
    • Hospital
    • Pharmacy
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のアデノシンデアミナーゼ欠損症の市場展望 (2018-2029)
  • 世界のアデノシンデアミナーゼ欠損症の市場成長トレンド:地域別
    • アデノシンデアミナーゼ欠損症 市場規模:地域別: 2018 VS 2022 VS 2029
    • アデノシンデアミナーゼ欠損症の市場規模実績:地域別 (2018-2023)
    • アデノシンデアミナーゼ欠損症の市場規模予測:地域別 (2024-2029)
  • アデノシンデアミナーゼ欠損症 市場動向
    • アデノシンデアミナーゼ欠損症 業界動向
    • アデノシンデアミナーゼ欠損症 市場の促進要因
    • アデノシンデアミナーゼ欠損症 市場の課題
    • アデノシンデアミナーゼ欠損症 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界規模の売上高 アデノシンデアミナーゼ欠損症 :競合別
    • 世界のアデノシンデアミナーゼ欠損症の収益:企業別 (2018-2023)
    • 世界のアデノシンデアミナーゼ欠損症の収益シェア:企業別 (2018-2023)
  • 世界のアデノシンデアミナーゼ欠損症の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 アデノシンデアミナーゼ欠損症, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界のアデノシンデアミナーゼ欠損症 市場集中度
    • 世界のアデノシンデアミナーゼ欠損症 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: アデノシンデアミナーゼ欠損症の収益 2022
  • 世界の主要企業 アデノシンデアミナーゼ欠損症 本社 および提供地域
  • 世界の主要企業 アデノシンデアミナーゼ欠損症, 製品およびアプリケーション
  • 世界の主要企業 アデノシンデアミナーゼ欠損症, 業界参入時期
  • M&A, 拡張計画

第4章 アデノシンデアミナーゼ欠損症 内訳データ:タイプ別

  • 世界のアデノシンデアミナーゼ欠損症の市場規模実績:タイプ別 (2018-2023)
  • 世界のアデノシンデアミナーゼ欠損症の市場規模予測:タイプ別 (2024-2029)

第5章 アデノシンデアミナーゼ欠損症 内訳データ:用途別

  • 世界のアデノシンデアミナーゼ欠損症の市場規模実績:用途別 (2018-2023)
  • 世界のアデノシンデアミナーゼ欠損症の市場規模予測:用途別 (2024-2029)

第6章 北米

  • 北米のアデノシンデアミナーゼ欠損症 市場規模 (2018-2029)
  • 北米のアデノシンデアミナーゼ欠損症 市場規模:タイプ別
    • 北米のアデノシンデアミナーゼ欠損症 市場規模:タイプ別 (2018-2023)
    • 北米のアデノシンデアミナーゼ欠損症 市場規模:タイプ別 (2024-2029)
    • 北米のアデノシンデアミナーゼ欠損症の市場シェア:タイプ別 (2018-2029)
  • 北米のアデノシンデアミナーゼ欠損症 市場規模:用途別
    • 北米のアデノシンデアミナーゼ欠損症 市場規模:用途別 (2018-2023)
    • 北米のアデノシンデアミナーゼ欠損症 市場規模:用途別 (2024-2029)
    • 北米のアデノシンデアミナーゼ欠損症の市場シェア:用途別 (2018-2029)
  • 北米のアデノシンデアミナーゼ欠損症 市場規模:国別
    • 北米のアデノシンデアミナーゼ欠損症 市場規模:国別: 2018 VS 2022 VS 2029
    • 北米のアデノシンデアミナーゼ欠損症 市場規模:国別 (2018-2023)
    • 北米のアデノシンデアミナーゼ欠損症 市場規模:国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のアデノシンデアミナーゼ欠損症 市場規模 (2018-2029)
  • 欧州のアデノシンデアミナーゼ欠損症 市場規模:タイプ別
    • 欧州のアデノシンデアミナーゼ欠損症 市場規模:タイプ別 (2018-2023)
    • 欧州のアデノシンデアミナーゼ欠損症 市場規模:タイプ別 (2024-2029)
    • 欧州のアデノシンデアミナーゼ欠損症の市場シェア:タイプ別 (2018-2029)
  • 欧州のアデノシンデアミナーゼ欠損症 市場規模:用途別
    • 欧州のアデノシンデアミナーゼ欠損症 市場規模:用途別 (2018-2023)
    • 欧州のアデノシンデアミナーゼ欠損症 市場規模:用途別 (2024-2029)
    • 欧州のアデノシンデアミナーゼ欠損症の市場シェア:用途別 (2018-2029)
  • 欧州のアデノシンデアミナーゼ欠損症 市場規模:国別
    • 欧州のアデノシンデアミナーゼ欠損症 市場規模:国別: 2018 VS 2022 VS 2029
    • 欧州のアデノシンデアミナーゼ欠損症 市場規模:国別 (2018-2023)
    • 欧州のアデノシンデアミナーゼ欠損症 市場規模:国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国のアデノシンデアミナーゼ欠損症 市場規模 (2018-2029)
  • 中国のアデノシンデアミナーゼ欠損症 市場規模:タイプ別
    • 中国のアデノシンデアミナーゼ欠損症 市場規模:タイプ別 (2018-2023)
    • 中国のアデノシンデアミナーゼ欠損症 市場規模:タイプ別 (2024-2029)
    • 中国のアデノシンデアミナーゼ欠損症の市場シェア:タイプ別 (2018-2029)
  • 中国のアデノシンデアミナーゼ欠損症 市場規模:用途別
    • 中国のアデノシンデアミナーゼ欠損症 市場規模:用途別 (2018-2023)
    • 中国のアデノシンデアミナーゼ欠損症 市場規模:用途別 (2024-2029)
    • 中国のアデノシンデアミナーゼ欠損症の市場シェア:用途別 (2018-2029)

第9章 アジア(中国を除く)

  • アジア地域 アデノシンデアミナーゼ欠損症 市場規模 (2018-2029)
  • アジア地域 アデノシンデアミナーゼ欠損症 市場規模:タイプ別
    • アジア地域 アデノシンデアミナーゼ欠損症 市場規模:タイプ別 (2018-2023)
    • アジア地域 アデノシンデアミナーゼ欠損症 市場規模:タイプ別 (2024-2029)
    • アジア地域 アデノシンデアミナーゼ欠損症の市場シェア:タイプ別 (2018-2029)
  • アジア地域 アデノシンデアミナーゼ欠損症 市場規模:用途別
    • アジア地域 アデノシンデアミナーゼ欠損症 市場規模:用途別 (2018-2023)
    • アジア地域 アデノシンデアミナーゼ欠損症 市場規模:用途別 (2024-2029)
    • アジア地域 アデノシンデアミナーゼ欠損症の市場シェア:用途別 (2018-2029)
  • アジア地域 アデノシンデアミナーゼ欠損症 市場規模:地域別
    • アジア地域 アデノシンデアミナーゼ欠損症 市場規模:地域別: 2018 VS 2022 VS 2029
    • アジア地域 アデノシンデアミナーゼ欠損症 市場規模:地域別 (2018-2023)
    • アジア地域 アデノシンデアミナーゼ欠損症 市場規模:地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模:タイプ別
    • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模:タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模:タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症の市場シェア:タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模:用途別
    • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模:用途別 (2018-2023)
    • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模:用途別 (2024-2029)
    • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症の市場シェア:用途別 (2018-2029)
  • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模:国別
    • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模:国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模:国別 (2018-2023)
    • 中近東・アフリカ・中南米 アデノシンデアミナーゼ欠損症 市場規模:国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Leadiant Biosciences
  • Chiesi

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Adenosine Deaminase Deficiency Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Adagen
  • Table 3. Key Players of Revcovi
  • Table 4. Global Adenosine Deaminase Deficiency Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 5. Global Adenosine Deaminase Deficiency Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 6. Global Adenosine Deaminase Deficiency Market Size by Region (2018-2023) & (US$ Million)
  • Table 7. Global Adenosine Deaminase Deficiency Market Share by Region (2018-2023)
  • Table 8. Global Adenosine Deaminase Deficiency Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 9. Global Adenosine Deaminase Deficiency Market Share by Region (2024-2029)
  • Table 10. Adenosine Deaminase Deficiency Market Trends
  • Table 11. Adenosine Deaminase Deficiency Market Drivers
  • Table 12. Adenosine Deaminase Deficiency Market Challenges
  • Table 13. Adenosine Deaminase Deficiency Market Restraints
  • Table 14. Global Adenosine Deaminase Deficiency Revenue by Players (2018-2023) & (US$ Million)
  • Table 15. Global Adenosine Deaminase Deficiency Revenue Share by Players (2018-2023)
  • Table 16. Global Top Adenosine Deaminase Deficiency by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenosine Deaminase Deficiency as of 2022)
  • Table 17. Global Adenosine Deaminase Deficiency Industry Ranking 2021 VS 2022 VS 2023
  • Table 18. Global 5 Largest Players Market Share by Adenosine Deaminase Deficiency Revenue (CR5 and HHI) & (2018-2023)
  • Table 19. Global Key Players of Adenosine Deaminase Deficiency, Headquarters and Area Served
  • Table 20. Global Key Players of Adenosine Deaminase Deficiency, Product and Application
  • Table 21. Global Key Players of Adenosine Deaminase Deficiency, Product and Application
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Adenosine Deaminase Deficiency Market Size by Type (2018-2023) & (US$ Million)
  • Table 24. Global Adenosine Deaminase Deficiency Revenue Market Share by Type (2018-2023)
  • Table 25. Global Adenosine Deaminase Deficiency Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 26. Global Adenosine Deaminase Deficiency Revenue Market Share by Type (2024-2029)
  • Table 27. Global Adenosine Deaminase Deficiency Market Size by Application (2018-2023) & (US$ Million)
  • Table 28. Global Adenosine Deaminase Deficiency Revenue Share by Application (2018-2023)
  • Table 29. Global Adenosine Deaminase Deficiency Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 30. Global Adenosine Deaminase Deficiency Revenue Share by Application (2024-2029)
  • Table 31. North America Adenosine Deaminase Deficiency Market Size by Type (2018-2023) & (US$ Million)
  • Table 32. North America Adenosine Deaminase Deficiency Market Size by Type (2024-2029) & (US$ Million)
  • Table 33. North America Adenosine Deaminase Deficiency Market Size by Application (2018-2023) & (US$ Million)
  • Table 34. North America Adenosine Deaminase Deficiency Market Size by Application (2024-2029) & (US$ Million)
  • Table 35. North America Adenosine Deaminase Deficiency Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 36. North America Adenosine Deaminase Deficiency Market Size by Country (2018-2023) & (US$ Million)
  • Table 37. North America Adenosine Deaminase Deficiency Market Size by Country (2024-2029) & (US$ Million)
  • Table 38. Europe Adenosine Deaminase Deficiency Market Size by Type (2018-2023) & (US$ Million)
  • Table 39. Europe Adenosine Deaminase Deficiency Market Size by Type (2024-2029) & (US$ Million)
  • Table 40. Europe Adenosine Deaminase Deficiency Market Size by Application (2018-2023) & (US$ Million)
  • Table 41. Europe Adenosine Deaminase Deficiency Market Size by Application (2024-2029) & (US$ Million)
  • Table 42. Europe Adenosine Deaminase Deficiency Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 43. Europe Adenosine Deaminase Deficiency Market Size by Country (2018-2023) & (US$ Million)
  • Table 44. Europe Adenosine Deaminase Deficiency Market Size by Country (2024-2029) & (US$ Million)
  • Table 45. China Adenosine Deaminase Deficiency Market Size by Type (2018-2023) & (US$ Million)
  • Table 46. China Adenosine Deaminase Deficiency Market Size by Type (2024-2029) & (US$ Million)
  • Table 47. China Adenosine Deaminase Deficiency Market Size by Application (2018-2023) & (US$ Million)
  • Table 48. China Adenosine Deaminase Deficiency Market Size by Application (2024-2029) & (US$ Million)
  • Table 49. Asia Adenosine Deaminase Deficiency Market Size by Type (2018-2023) & (US$ Million)
  • Table 50. Asia Adenosine Deaminase Deficiency Market Size by Type (2024-2029) & (US$ Million)
  • Table 51. Asia Adenosine Deaminase Deficiency Market Size by Application (2018-2023) & (US$ Million)
  • Table 52. Asia Adenosine Deaminase Deficiency Market Size by Application (2024-2029) & (US$ Million)
  • Table 53. Asia Adenosine Deaminase Deficiency Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 54. Asia Adenosine Deaminase Deficiency Market Size by Region (2018-2023) & (US$ Million)
  • Table 55. Asia Adenosine Deaminase Deficiency Market Size by Region (2024-2029) & (US$ Million)
  • Table 56. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Type (2018-2023) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Type (2024-2029) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Application (2018-2023) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Application (2024-2029) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 61. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Country (2018-2023) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Country (2024-2029) & (US$ Million)
  • Table 63. Leadiant Biosciences Company Details
  • Table 64. Leadiant Biosciences Business Overview
  • Table 65. Leadiant Biosciences Adenosine Deaminase Deficiency Product
  • Table 66. Leadiant Biosciences Revenue in Adenosine Deaminase Deficiency Business (2018-2023) & (US$ Million)
  • Table 67. Leadiant Biosciences Recent Developments
  • Table 68. Chiesi Company Details
  • Table 69. Chiesi Business Overview
  • Table 70. Chiesi Adenosine Deaminase Deficiency Product
  • Table 71. Chiesi Revenue in Adenosine Deaminase Deficiency Business (2018-2023) & (US$ Million)
  • Table 72. Chiesi Recent Developments
  • Table 73. Research Programs/Design for This Report
  • Table 74. Key Data Information from Secondary Sources
  • Table 75. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Adenosine Deaminase Deficiency Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Adenosine Deaminase Deficiency Market Share by Type: 2022 VS 2029
  • Figure 3. Adagen Features
  • Figure 4. Revcovi Features
  • Figure 5. Global Adenosine Deaminase Deficiency Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 6. Global Adenosine Deaminase Deficiency Market Share by Application: 2022 VS 2029
  • Figure 7. Hospital Case Studies
  • Figure 8. Pharmacy Case Studies
  • Figure 9. Adenosine Deaminase Deficiency Report Years Considered
  • Figure 10. Global Adenosine Deaminase Deficiency Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 11. Global Adenosine Deaminase Deficiency Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 12. Global Adenosine Deaminase Deficiency Market Share by Region: 2022 VS 2029
  • Figure 13. Global Adenosine Deaminase Deficiency Market Share by Players in 2022
  • Figure 14. Global Top Adenosine Deaminase Deficiency Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenosine Deaminase Deficiency as of 2022)
  • Figure 15. The Top 10 and 5 Players Market Share by Adenosine Deaminase Deficiency Revenue in 2022
  • Figure 16. North America Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 17. North America Adenosine Deaminase Deficiency Market Share by Type (2018-2029)
  • Figure 18. North America Adenosine Deaminase Deficiency Market Share by Application (2018-2029)
  • Figure 19. North America Adenosine Deaminase Deficiency Market Share by Country (2018-2029)
  • Figure 20. United States Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 21. Canada Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 22. Europe Adenosine Deaminase Deficiency Market Size YoY (2018-2029) & (US$ Million)
  • Figure 23. Europe Adenosine Deaminase Deficiency Market Share by Type (2018-2029)
  • Figure 24. Europe Adenosine Deaminase Deficiency Market Share by Application (2018-2029)
  • Figure 25. Europe Adenosine Deaminase Deficiency Market Share by Country (2018-2029)
  • Figure 26. Germany Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 27. France Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 28. U.K. Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. Italy Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. Russia Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Nordic Countries Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. China Adenosine Deaminase Deficiency Market Size YoY (2018-2029) & (US$ Million)
  • Figure 33. China Adenosine Deaminase Deficiency Market Share by Type (2018-2029)
  • Figure 34. China Adenosine Deaminase Deficiency Market Share by Application (2018-2029)
  • Figure 35. Asia Adenosine Deaminase Deficiency Market Size YoY (2018-2029) & (US$ Million)
  • Figure 36. Asia Adenosine Deaminase Deficiency Market Share by Type (2018-2029)
  • Figure 37. Asia Adenosine Deaminase Deficiency Market Share by Application (2018-2029)
  • Figure 38. Asia Adenosine Deaminase Deficiency Market Share by Region (2018-2029)
  • Figure 39. Japan Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 40. South Korea Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 41. China Taiwan Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. Southeast Asia Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. India Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. Australia Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size YoY (2018-2029) & (US$ Million)
  • Figure 46. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Share by Type (2018-2029)
  • Figure 47. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Share by Application (2018-2029)
  • Figure 48. Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Share by Country (2018-2029)
  • Figure 49. Brazil Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 50. Mexico Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 51. Turkey Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 52. Saudi Arabia Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Israel Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. GCC Countries Adenosine Deaminase Deficiency Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Leadiant Biosciences Revenue Growth Rate in Adenosine Deaminase Deficiency Business (2018-2023)
  • Figure 56. Chiesi Revenue Growth Rate in Adenosine Deaminase Deficiency Business (2018-2023)
  • Figure 57. Bottom-up and Top-down Approaches for This Report
  • Figure 58. Data Triangulation
  • Figure 59. Key Executives Interviewed
目次

This research report focuses on the Adenosine Deaminase Deficiency Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Adenosine Deaminase Deficiency Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Adagen
    • 1.2.3 Revcovi
  • 1.3 Market by Application
    • 1.3.1 Global Adenosine Deaminase Deficiency Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospital
    • 1.3.3 Pharmacy
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Adenosine Deaminase Deficiency Market Perspective (2018-2029)
  • 2.2 Global Adenosine Deaminase Deficiency Growth Trends by Region
    • 2.2.1 Adenosine Deaminase Deficiency Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Adenosine Deaminase Deficiency Historic Market Size by Region (2018-2023)
    • 2.2.3 Adenosine Deaminase Deficiency Forecasted Market Size by Region (2024-2029)
  • 2.3 Adenosine Deaminase Deficiency Market Dynamics
    • 2.3.1 Adenosine Deaminase Deficiency Industry Trends
    • 2.3.2 Adenosine Deaminase Deficiency Market Drivers
    • 2.3.3 Adenosine Deaminase Deficiency Market Challenges
    • 2.3.4 Adenosine Deaminase Deficiency Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Adenosine Deaminase Deficiency by Players
    • 3.1.1 Global Adenosine Deaminase Deficiency Revenue by Players (2018-2023)
    • 3.1.2 Global Adenosine Deaminase Deficiency Revenue Market Share by Players (2018-2023)
  • 3.2 Global Adenosine Deaminase Deficiency Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Adenosine Deaminase Deficiency, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Adenosine Deaminase Deficiency Market Concentration Ratio
    • 3.4.1 Global Adenosine Deaminase Deficiency Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Adenosine Deaminase Deficiency Revenue in 2022
  • 3.5 Global Key Players of Adenosine Deaminase Deficiency Head office and Area Served
  • 3.6 Global Key Players of Adenosine Deaminase Deficiency, Product and Application
  • 3.7 Global Key Players of Adenosine Deaminase Deficiency, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Adenosine Deaminase Deficiency Breakdown Data by Type

  • 4.1 Global Adenosine Deaminase Deficiency Historic Market Size by Type (2018-2023)
  • 4.2 Global Adenosine Deaminase Deficiency Forecasted Market Size by Type (2024-2029)

5 Adenosine Deaminase Deficiency Breakdown Data by Application

  • 5.1 Global Adenosine Deaminase Deficiency Historic Market Size by Application (2018-2023)
  • 5.2 Global Adenosine Deaminase Deficiency Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Adenosine Deaminase Deficiency Market Size (2018-2029)
  • 6.2 North America Adenosine Deaminase Deficiency Market Size by Type
    • 6.2.1 North America Adenosine Deaminase Deficiency Market Size by Type (2018-2023)
    • 6.2.2 North America Adenosine Deaminase Deficiency Market Size by Type (2024-2029)
    • 6.2.3 North America Adenosine Deaminase Deficiency Market Share by Type (2018-2029)
  • 6.3 North America Adenosine Deaminase Deficiency Market Size by Application
    • 6.3.1 North America Adenosine Deaminase Deficiency Market Size by Application (2018-2023)
    • 6.3.2 North America Adenosine Deaminase Deficiency Market Size by Application (2024-2029)
    • 6.3.3 North America Adenosine Deaminase Deficiency Market Share by Application (2018-2029)
  • 6.4 North America Adenosine Deaminase Deficiency Market Size by Country
    • 6.4.1 North America Adenosine Deaminase Deficiency Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Adenosine Deaminase Deficiency Market Size by Country (2018-2023)
    • 6.4.3 North America Adenosine Deaminase Deficiency Market Size by Country (2024-2029)
    • 6.4.4 the United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Adenosine Deaminase Deficiency Market Size (2018-2029)
  • 7.2 Europe Adenosine Deaminase Deficiency Market Size by Type
    • 7.2.1 Europe Adenosine Deaminase Deficiency Market Size by Type (2018-2023)
    • 7.2.2 Europe Adenosine Deaminase Deficiency Market Size by Type (2024-2029)
    • 7.2.3 Europe Adenosine Deaminase Deficiency Market Share by Type (2018-2029)
  • 7.3 Europe Adenosine Deaminase Deficiency Market Size by Application
    • 7.3.1 Europe Adenosine Deaminase Deficiency Market Size by Application (2018-2023)
    • 7.3.2 Europe Adenosine Deaminase Deficiency Market Size by Application (2024-2029)
    • 7.3.3 Europe Adenosine Deaminase Deficiency Market Share by Application (2018-2029)
  • 7.4 Europe Adenosine Deaminase Deficiency Market Size by Country
    • 7.4.1 Europe Adenosine Deaminase Deficiency Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Adenosine Deaminase Deficiency Market Size by Country (2018-2023)
    • 7.4.3 Europe Adenosine Deaminase Deficiency Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Adenosine Deaminase Deficiency Market Size (2018-2029)
  • 8.2 China Adenosine Deaminase Deficiency Market Size by Type
    • 8.2.1 China Adenosine Deaminase Deficiency Market Size by Type (2018-2023)
    • 8.2.2 China Adenosine Deaminase Deficiency Market Size by Type (2024-2029)
    • 8.2.3 China Adenosine Deaminase Deficiency Market Share by Type (2018-2029)
  • 8.3 China Adenosine Deaminase Deficiency Market Size by Application
    • 8.3.1 China Adenosine Deaminase Deficiency Market Size by Application (2018-2023)
    • 8.3.2 China Adenosine Deaminase Deficiency Market Size by Application (2024-2029)
    • 8.3.3 China Adenosine Deaminase Deficiency Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Adenosine Deaminase Deficiency Market Size (2018-2029)
  • 9.2 Asia Adenosine Deaminase Deficiency Market Size by Type
    • 9.2.1 Asia Adenosine Deaminase Deficiency Market Size by Type (2018-2023)
    • 9.2.2 Asia Adenosine Deaminase Deficiency Market Size by Type (2024-2029)
    • 9.2.3 Asia Adenosine Deaminase Deficiency Market Share by Type (2018-2029)
  • 9.3 Asia Adenosine Deaminase Deficiency Market Size by Application
    • 9.3.1 Asia Adenosine Deaminase Deficiency Market Size by Application (2018-2023)
    • 9.3.2 Asia Adenosine Deaminase Deficiency Market Size by Application (2024-2029)
    • 9.3.3 Asia Adenosine Deaminase Deficiency Market Share by Application (2018-2029)
  • 9.4 Asia Adenosine Deaminase Deficiency Market Size by Region
    • 9.4.1 Asia Adenosine Deaminase Deficiency Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Adenosine Deaminase Deficiency Market Size by Region (2018-2023)
    • 9.4.3 Asia Adenosine Deaminase Deficiency Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Adenosine Deaminase Deficiency Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Leadiant Biosciences
    • 11.1.1 Leadiant Biosciences Company Details
    • 11.1.2 Leadiant Biosciences Business Overview
    • 11.1.3 Leadiant Biosciences Adenosine Deaminase Deficiency Introduction
    • 11.1.4 Leadiant Biosciences Revenue in Adenosine Deaminase Deficiency Business (2018-2023)
    • 11.1.5 Leadiant Biosciences Recent Developments
  • 11.2 Chiesi
    • 11.2.1 Chiesi Company Details
    • 11.2.2 Chiesi Business Overview
    • 11.2.3 Chiesi Adenosine Deaminase Deficiency Introduction
    • 11.2.4 Chiesi Revenue in Adenosine Deaminase Deficiency Business (2018-2023)
    • 11.2.5 Chiesi Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details